SC 13G | 2024-02-14 | RTW INVESTMENTS, LP | ACADIA PHARMACEUTICALS INC | 11,253,551 | 6.9% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | ACADIA PHARMACEUTICALS INC | 13,396,009 | 8.2% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | ACADIA PHARMACEUTICALS INC | 5,265,357 | 3.2% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | ACADIA PHARMACEUTICALS INC | 11,409,218 | 6.9% | EDGAR |
SC 13D/A | 2023-05-24 | BAKER BROS. ADVISORS LP | ACADIA PHARMACEUTICALS INC | 43,084,280 | 26.5% | EDGAR |
SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | ACADIA PHARMACEUTICALS INC | 4,279,254 | 2.6% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | ACADIA PHARMACEUTICALS INC | 9,334,613 | 5.8% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | ACADIA PHARMACEUTICALS INC | 13,279,775 | 8.2% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | ACADIA PHARMACEUTICALS INC | 10,258,738 | 6.3% | EDGAR |
SC 13D/A | 2023-01-17 | BAKER BROS. ADVISORS LP | ACADIA PHARMACEUTICALS INC | 42,163,470 | 26.0% | EDGAR |
SC 13G | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | ACADIA PHARMACEUTICALS INC | 9,486,261 | 5.9% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | ACADIA PHARMACEUTICALS INC | 13,840,750 | 8.6% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | ACADIA PHARMACEUTICALS INC | 12,315,366 | 7.7% | EDGAR |
SC 13G | 2022-02-04 | BlackRock Inc. | ACADIA PHARMACEUTICALS INC | 10,060,312 | 6.3% | EDGAR |
SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | ACADIA PHARMACEUTICALS INC | 7,877,825 | 4.9% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | ACADIA PHARMACEUTICALS INC | 10,605,773 | 6.7% | EDGAR |
SC 13G/A | 2021-02-08 | FMR LLC | ACADIA PHARMACEUTICALS INC | 19,472,913 | 12.2% | EDGAR |
SC 13G/A | 2020-07-10 | BlackRock Inc. | ACADIA PHARMACEUTICALS INC | 7,757,846 | 5.0% | EDGAR |
SC 13G | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | ACADIA PHARMACEUTICALS INC | 13,241,014 | 8.5% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | ACADIA PHARMACEUTICALS INC | 10,616,613 | 6.9% | EDGAR |